` OVB (Ovoca Bio PLC) vs FTSE All Share Index Comparison - Alpha Spread

OVB
vs
F
FTSE All Share Index

Over the past 12 months, OVB has outperformed FTSE All Share Index, delivering a return of -26% compared to the FTSE All Share Index's 0% growth.

Stocks Performance
OVB vs FTSE All Share Index

Loading
OVB
FTSE All Share Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
OVB vs FTSE All Share Index

Loading
OVB
FTSE All Share Index
Difference
www.alphaspread.com

Performance By Year
OVB vs FTSE All Share Index

Loading
OVB
FTSE All Share Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Ovoca Bio PLC vs Peers

FTSE All Share Index
OVB
LLY
JNJ
ROG
AZN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Ovoca Bio PLC
Glance View

Market Cap
1m GBX
Industry
Pharmaceuticals

Ovoca Bio Plc is a clinical-stage biopharmaceutical company. The company is headquartered in Dublin, Dublin and currently employs 5 full-time employees. The firm is engaged in identifying and developing therapeutics targeting the treatment of female sexual dysfunction. The Company’s product BP101 is a synthetic peptide, administered through a nasal spray that is being developed for the treatment of female sexual dysfunction-hypoactive sexual desire disorder (HSDD). The Company’s subsidiaries include Silver Star Ltd, Bulun LLC, Magsel LLC, IVIX LLC and OVB (Australia) Pty Ltd. The firm operates in Ireland, the United Kingdom (UK) and Russia.

OVB Intrinsic Value
2.48 GBX
Undervaluation 54%
Intrinsic Value
Price
Back to Top